Commercial, Solar, Sourcing Renewables - January 17, 2024
AstraZeneca, Lonza, Novartis, Novo Nordisk, Roche Sign RE Agreement
AstraZeneca, Lonza, Novartis, Novo Nordisk and Roche signed a three-year renewable energy supply agreement for 200 gigawatt-hours (GWh) of green power annually, starting in 2024.
The agreement between the five pharmaceutical companies and Envision Energy, a green technology company, will result in annual carbon dioxide equivalent savings of approximately 120,000 tons, according to a statement.
The three-year renewable energy supply agreement was announced during the World Economic Forum Annual Meeting in Davos, Switzerland.
Four of the companies - AstraZeneca, Novartis, Novo Nordisk, and Roche - are members of the Sustainable Markets Initiative Health Systems Task Force, which was launched by His Majesty King Charles III.
Read These Related Articles:
Stay Up-To-Date
